2–13 Surveillance of BRCA1 and BRCA2 Mutation Carriers With Magnetic Resonance Imaging, Ultrasound, Mammography, and Clinical Breast Examination

By P. Dempsey. 2005

736 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

From cancer patient to cancer survivor : lost in transition (2006, background): “, breast self-examination, clinical breast examinations, annual mammograms, magnetic resonance imaging (MRI) examinations) (Warner et al., 2004), and ovarian cancer detection tools (e.”
Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. (2010, background): “strated superior sensitivity of MRI for cancer detection in high-risk women [61,63,80].”
Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. (2008, background): “Our results should be interpreted in the context of recent guidelines recommending annual MRI in women at very high risk of breast cancer.”
Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. (2010, background): “75 However, the absence of randomisation in these studies introduced significant bias because of the inclusion of smaller and less aggressive tumours in the group who underwent MRI.”